Hormone replacement therapy: An update

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2010, Vol 27, Issue 5

Abstract

Because of the discrepancies in opinions about the benefits and risks of hormone replacement therapy (HRT), recently the International Menopause Society formulated a consensus statement concerning HRT. For women experiencing menopause before the age of 45 years, HRT is recommended until at least the age of 50 years. HRT in women <60 years of age reduces the risk of coronary heart disease, but it may be harmful when administered to older women in whom the endothelium has already undergone the process of atherosclerosis. Combined estrogen and progesterone therapy may lead to a small increase in the risk for breast cancer, but the risk for breast cancer has been shown to be not increased, or increased only slightly after several years of treatment in women treated with estrogen only following hysterectomy. HRT increases the risk of stroke and thromboembolism, but this risk is very low among women aged <60 years. HRT remains the most effective treatment for the vasomotor symptoms of menopause, it has a beneficial effect on connective tissue, skin, joints and intervertebral discs, and in some cases on the quality of life and sexuality. HRT reduces the risk of colorectal cancer and the incidence of all fractures (related to osteoporosis). HRT improves insulin resistance, reduces the risk of type 2 diabetes mellitus and has a positive effect on lipid levels and the metabolic syndrome. HRT lowers mortality by approximately 30% when administered to women aged <60 years, possibly due to protection from coronary heart disease. According to current recommendations, when indicated, and when administered within a few years after menopause, HRT is associated with more benefits than risks. The decision to treat a woman with HRT should be individualized and women on HRT should have regular follow up.

Authors and Affiliations

E. KOUSTA, G. TOLIS

Keywords

Related Articles

Medical, social and economic implications of computed tomography and the evolution of multislice computed tomography scanners

Studies show that in the USA the radiation generated by computed tomography (CT) examinations causes annually 3,000 fatal cancers, while the increasing trend in its use reaches 10%, overloading the budget of society. The...

CMV enteritis

No abstract available

Curative strategies in acute myeloid leukemia in younger adults

The treatment of acute myeloid leukemia (ΑML) generally involves the administration of cytotoxic chemotherapy to eradicate the malignant cells, which permits restoration of normal hematopoiesis by normal residual stem ce...

Εκτίμηση της αδελφικής σχέσης ανάμεσα σε δύο άτομα με ανάλυση DΝΑ<br /> στον Ελληνικό πληθυσμό

ΣΚΟΠΟΣ Με την ανάλυση DNA μπορεί να προσδιοριστεί αν δύο άτομα είναι αδέλφια, ακόμη και αν δεν είναι διαθέσιμο δείγμα των γονέων. Σκοπός αυτής της εργασίας είναι να προσδιοριστεί η αξιοπιστία της ανάλυσης συγγένειας στον...

Recent therapeutic developments in the antiphospholipid syndrome

The antiphospholipid syndrome is characterized by thrombosis, recurrent abortions and detection of antiphospholipid antibodies. The management of acute arterial and venous thrombosis is no different from that of thrombos...

Download PDF file
  • EP ID EP139576
  • DOI -
  • Views 95
  • Downloads 0

How To Cite

E. KOUSTA, G. TOLIS (2010). Hormone replacement therapy: An update . Αρχεία Ελληνικής Ιατρικής, 27(5), 776-782. https://europub.co.uk/articles/-A-139576